Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

NCT01803022 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01803022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01803022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
Lead sponsor
LEO Pharma
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
July 31, 2013
Enrollment
419 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism